{"organizations": [], "uuid": "95160e6e504cf4c60859857037bfdea71d447d0f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180504.html", "section_title": "Archive News &amp; Video for Friday, 04 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/lonza-results/lonza-confirms-targets-as-q1-gets-off-to-good-start-idUSZ8N1RJ00N", "country": "US", "domain_rank": 408, "title": "Lonza confirms targets as Q1 gets off to good start", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-04T13:18:00.000+03:00", "replies_count": 0, "uuid": "95160e6e504cf4c60859857037bfdea71d447d0f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/lonza-results/lonza-confirms-targets-as-q1-gets-off-to-good-start-idUSZ8N1RJ00N", "ord_in_thread": 0, "title": "Lonza confirms targets as Q1 gets off to good start", "locations": [], "entities": {"persons": [{"name": "michael shields", "sentiment": "none"}, {"name": "tom sims", "sentiment": "none"}], "locations": [{"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "lonza", "sentiment": "negative"}, {"name": "ebitda", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ZURICH, May 4 (Reuters) - Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.\n“Lonza confirms ongoing strong momentum for its businesses along the healthcare continuum and is confident to achieve a positive half-year result 2018,” it said without giving detailed financial figures.\n“The strong business momentum also makes Lonza fully confident of achieving, at a minimum, the previously communicated full-year guidance of mid-single-digit sales growth on a comparable basis in line with mid-term guidance 2022 and 100 (basis point) improvement in core EBITDA margin in line with mid-term guidance 2022,” it added.\nLonza in January forecast a 2018 operating profit margin that fell short of market expectations. (Reporting by Michael Shields Editing by Tom Sims )\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-04T13:18:00.000+03:00", "crawled": "2018-05-05T12:23:16.064+03:00", "highlightTitle": ""}